Printer Friendly

EDITEK ANNOUNCES ADVERSE RULING IN DISEASE DETECTION ARBITRATION

 BURLINGTON, N.C., Aug. 11 /PRNewswire/ -- EDITEK, Inc. (AMEX: EDI.EC) announced today that it has received an unfavorable decision in an arbitration proceeding between EDITEK and Disease Detection International (DDI).
 The arbitrator has ruled that the license agreement between EDITEK and DDI was wrongfully terminated by EDITEK in 1988 and as such, remains in force. No monetary damages were awarded against EDITEK, but the arbitrator has ruled that DDI can recover its costs and attorneys fees which are still to be determined. EDITEK believes DDI's attorneys fees will be substantial. Under the terms of the license agreement DDI has the exclusive right to use the licensed technology, which includes most of EDITEK's patents, to make, use, and sell products in the field of infectious disease diagnostic testing in animals and humans and to detect pregnancy and ovulation hormones in humans. The ruling does not prevent EDITEK from operating in these fields using technology other than the licensed technology.
 Jim Skinner, president and CEO of EDITEK, stated, "We are very surprised by and disappointed with the arbitrator's ruling. We at EDITEK, including our legal counsel, were of the opinion that the license agreement had been terminated five years ago. On this basis, EDITEK had initiated product development and other efforts using the licensed technology in all fields of use. Currently, EDITEK has no products commercially available in the fields of use covered by the license agreement. This ruling does not affect EDITEK's primary lines of business such as the development and sale of products for detection of drugs of abuse, agricultural diagnostic products and tests for environmental substances of a biological origin for the U.S. Department of Defense. EDITEK has and will continue to aggressively pursue these and other market opportunities."
 -0- 8/11/93
 /CONTACT: Peter Heath, vice president finance and chief financial officer of EDITEK, 919-226-6311/
 (EDI.EC)


CO: EDITEK, Inc. ST: North Carolina IN: SU:

PS -- NY009 -- 1471 08/11/93 07:01 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 11, 1993
Words:328
Previous Article:TEXAS BIOTECHNOLOGY AND PHARMACEUTICAL DISCOVERY CORPORATION FORM STRATEGIC AGREEMENT
Next Article:NATURAL HARDWOODS MAKE ENVIRONMENTAL SENSE IN THE HOME; WISE MANAGEMENT HELPS THE FOREST RESOURCE RENEW ITSELF
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters